feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Weight Drugs Cause Muscle Loss: Exercise is Key

Weight Drugs Cause Muscle Loss: Exercise is Key

9 Dec, 2025

•

Summary

  • Weight-loss drugs cause significant muscle and bone mass loss.
  • Strength training is crucial to limit muscle mass loss.
  • UK gyms are urged to create tailored programs for users.
Weight Drugs Cause Muscle Loss: Exercise is Key

Weight-loss medications, including popular GLP-1 receptor agonists, are associated with rapid fat loss but also significant lean muscle mass reduction. This muscle loss mirrors that seen in conditions like cancer, following bariatric surgery, or due to advanced aging. Such effects can heighten the risk of frailty and falls among older adults, presenting a considerable healthcare burden.

To counteract these risks, strength training has emerged as a vital component of treatment. Experts emphasize that regular strength exercises are essential for maintaining bodily integrity and achieving sustainable results alongside weight loss. The fitness sector, including organizations like UKActive and Les Mills, is calling for governmental support to develop comprehensive programs for patients.

These weight-loss drugs function by mimicking natural hormones to regulate blood sugar and appetite, thereby reducing calorie intake. While effective for weight reduction, the NHS and NICE recommend their use in conjunction with dietary changes and exercise. A new report suggests that UK gyms should partner with the government to offer specialized exercise plans, ensuring users maintain muscle mass and promote long-term health.

trending

Earthquake hits Southern California

trending

Bill Self hospitalized in Kansas

trending

Nick Saban docuseries announced

trending

Aurora borealis visible tonight

trending

Michigan 100-vehicle pileup closes I-196

trending

Bucks beat Hawks, end skid

trending

Madison Keys advances at Australian Open

trending

Cignetti: Best college coach

trending

Thunder crush Cavaliers 136-104

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Yes, drugs such as Mounjaro and Wegovy can lead to significant lean muscle loss, comparable to levels seen in cancer treatment or bariatric surgery.
Regular strength training is highly recommended to limit muscle mass loss associated with significant weight reduction.
The NHS advises that weight loss drugs should be used alongside dietary changes and consistent exercise, particularly strength training.

Read more news on

Healthside-arrow

You may also like

Passenger Weight Loss Saves Airlines Millions

1 day ago • 35 reads

article image

Weight Loss Jabs Reshape Restaurant Menus

17 Jan • 10 reads

article image

Ozempic Launches in India: Diabetes & Weight Game-Changer?

12 Dec, 2025 • 176 reads

article image

Cats Get Their Own Weight-Loss Drug Implant

11 Dec, 2025 • 188 reads

New Obesity Drug Aleniglipron Shows Promising Weight Loss

9 Dec, 2025 • 181 reads

article image